
The First Bioreactor Capsule for Testing Organism-Cell Compatibility Developed at SibSMU
The polycaprolactone shell is attached to a large neurovascular bundle and receives natural nourishment

The polycaprolactone shell is attached to a large neurovascular bundle and receives natural nourishment

SibGMU's development will help identify the risk of lung and bone problems in infants weighing from 500g to 1.5kg in advance

The medicine will be widely used in surgery, therapy, and cardiology

The device may allow restoring fine motor skills of fingers with the help of robotic mechanotherapy

Fillers are granules-microspheres

The development will allow testing the toxicity of gene-therapeutic drugs

The device operates on the basis of artificial intelligence